|


Published:
Journal of Analytical Toxicology,
ISSN 0146-4760,
Volume 26,
Number 1, January/February 2002, pp. 48-51
TECHNICAL NOTE: Salting Out Improves Solid-Phase Extraction
Recoveries on Abselut-Tox Columns for Broad Spectrum Drug Screening
Jan Bosman, Jaap Wijsbeek, Jan Piet Franke, and Rokus A.
de Zeeuw* Department of Analytical Chemistry and Toxicology, University Centre
for Pharmacy, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
Broad-spectrum drug screening is frequently applied in forensic
and clinical toxicology, drugs and driving and doping, for example. It requires
that all toxicologically relevant substances be isolated, detected, and identified,
regardless their structure and/or polarity. This comprehensive screening is
also known as Systematic Toxicological Analysis (STA).
Solid-phase extraction (SPE) has become the technique of choice
for sample work up and isolation in STA (14). The key issues in this step
are to retain all relevant toxicants and at the same time to remove all non-relevant
substances and interferences, particularly matrix components.
Recently, Abselut-Tox columns were introduced by Varian Sample
Preparation Products (Harbor City, CA) as a new material for screening purposes
by SPE. In fact, the first three letters in the name stand for acidic/basic
screen. The material is a styrene-divinylbenzene copolymer (SDVB) with optimal
particle and pore sizes to allow high and reproducible flow rates. Among the
claimed advantages are no channeling, no pH instability, no secondary interactions,
excellent mass transfer, and high capacities.
However, it should be noted that these columns exhibit a single
retention mechanism, specifically relatively weak hydrophobic interactions between
the SDVB skeleton and the drug of interest. Given the fact that toxicologically
relevant substances may differ widely in character (acidic, neutral, basic,
zwitterionic) and/or in polarity, this may cause difficulties in developing
a suitable SPE methodology that provides adequate recoveries of all substances
of interest and that allows satisfactory removal of matrix interferences at
the same time.
This paper describes our experiences with Abselut-Tox SPE columns
for broad spectrum drug screening in plasma. The Abselut-Tox columns should
not be confused with Abselut-Nexus columns; the latter provide a more complicated
interaction mechanism. When selecting our test drugs, we focused particularly
on strongly acidic substances and/or polar substances because these are known
to be problematic in both SPE and in liquidliquid extractions.
Reproduction
of editorial content of this journal is prohibited without publishers
permission.
This
article is available in its entirety by fax for $4.00 per
page.
Visa or MasterCard accepted. To order electronically click here
or call: 847-647-2900 ext. 1323
or fax request to: 847-647-1155.
Please indicate JAT
volume and issue along with page numbers. |
|
Home | Subscribe
| Current Issue | Back Issues
| Search | Advertise | Other Publications
| |